Consistently with previous studies (70), the addition of ATRA increased CD1d expression and potentiated Vγ9Vδ2 T-cell engager-induced cytotoxicity of CLL cells (69). The gene discussed is CD1D; the disease is B-cell chronic lymphocytic leukemia.